(Q38069916)

28 August 2017

1 reference

title

Elevated risk of asthma after hospitalization for respiratory syncytial virus infection in infancy (English)

1 reference

28 August 2017

0 references

1 reference

1 reference

Shelagh M Szabo

1

1 reference

28 August 2017

Adrian R Levy

2

1 reference

28 August 2017

Katherine L Gooch

3

1 reference

28 August 2017

Pamela Bradt

4

1 reference

28 August 2017

Hardy Wijaya

5

1 reference

28 August 2017

Ian Mitchell

6

1 reference

28 August 2017

1 January 2013

1 reference

Paediatric Respiratory Reviews

28 August 2017

1 reference

28 August 2017

13 Suppl 2

1 reference

28 August 2017

S9-15

1 reference

Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13.

28 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2812%2970161-6

7 January 2021

Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life.

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2812%2970161-6

7 January 2021

Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: a longitudinal birth cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2812%2970161-6

7 January 2021

Respiratory morbidity 20 years after RSV infection in infancy

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2812%2970161-6

7 January 2021

Respiratory morbidity in adulthood after respiratory syncytial virus hospitalization in infancy

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2812%2970161-6

7 January 2021

Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC)

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2812%2970161-6

7 January 2021

Airflow limitation during respiratory syncytial virus lower respiratory tract infection predicts recurrent wheezing.

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2812%2970161-6

7 January 2021

Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7.

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2812%2970161-6

7 January 2021

Association of an early respiratory syncytial virus infection and atopic allergy

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2812%2970161-6

7 January 2021

Outcome of acute lower respiratory tract infection in infants: preliminary report of seven-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2812%2970161-6

7 January 2021

Asthma, lung function and sensitization in school children with a history of bronchiolitis

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2812%2970161-6

7 January 2021

Childhood asthma following hospitalization with acute viral bronchiolitis in infancy

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2812%2970161-6

7 January 2021

Acute bronchiolitis in infancy as risk factor for wheezing and reduced pulmonary function by seven years in Akershus County, Norway

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2812%2970161-6

7 January 2021

Long-term prospective study in children after respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2812%2970161-6

7 January 2021

Recurrent wheezing after respiratory syncytial virus or non-respiratory syncytial virus bronchiolitis in infancy: a 3-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2812%2970161-6

7 January 2021

Predictors of asthma three years after hospital admission for wheezing in infancy

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2812%2970161-6

7 January 2021

Respiratory syncytial virus infection in children hospitalized for wheezing: virus-specific studies from infancy to preschool years.

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2812%2970161-6

7 January 2021

Teenage asthma after severe early childhood wheezing: an 11-year prospective follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2812%2970161-6

7 January 2021

Wheezing bronchitis reinvestigated at the age of 10 years

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2812%2970161-6

7 January 2021

Asthma symptoms in early childhood--what happens then?

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2812%2970161-6

7 January 2021

Bronchial asthma after early childhood wheezing: a follow-up until 4.5-6 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2812%2970161-6

7 January 2021

Bronchial asthma and hyperreactivity after early childhood bronchiolitis or pneumonia. An 8-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2812%2970161-6

7 January 2021

Teenage asthma after severe infantile bronchiolitis or pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2812%2970161-6

7 January 2021

Adult asthma after non-respiratory syncytial virus bronchiolitis in infancy: subgroup analysis of the 20-year prospective follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2812%2970161-6

7 January 2021

Human metapneumovirus bronchiolitis in infancy is an important risk factor for asthma at age 5

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2812%2970161-6

7 January 2021

The association between respiratory syncytial virus infection and the development of childhood asthma: a systematic review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2812%2970161-6

7 January 2021

Do early-life viral infections cause asthma?

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2812%2970161-6

7 January 2021

The relationship of RSV-specific immunoglobulin E antibody responses in infancy, recurrent wheezing, and pulmonary function at age 7-8 years

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2812%2970161-6

7 January 2021

Predictive value of respiratory syncytial virus-specific IgE responses for recurrent wheezing following bronchiolitis

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2812%2970161-6

7 January 2021

The relationship between proved viral bronchiolitis and subsequent wheezing

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2812%2970161-6

7 January 2021

IL-13 genetic polymorphism identifies children with late wheezing after respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2812%2970161-6

7 January 2021

The global burden of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2812%2970161-6

7 January 2021

Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2812%2970161-6

7 January 2021

Respiratory syncytial virus infection and recurrent wheezing: a complex relationship

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2812%2970161-6

7 January 2021

Causal links between RSV infection and asthma: no clear answers to an old question

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2812%2970161-6

7 January 2021

Heterogeneity in meta-analysis of data from epidemiologic studies: a commentary

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2812%2970161-6

7 January 2021

Flow limitation in normal infants: a new method for forced expiratory maneuvers from raised lung volumes

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2812%2970161-6

7 January 2021

Adult-type pulmonary function tests in infants without respiratory disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2812%2970161-6

7 January 2021

The effect of high dose inhaled corticosteroids on wheeze in infants after respiratory syncytial virus infection: randomised double blind placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2812%2970161-6

7 January 2021

Operational definitions of asthma in studies on its aetiology

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2812%2970161-6

7 January 2021

Tucson Children's Respiratory Study: 1980 to present

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2812%2970161-6

7 January 2021

10.1016/S1526-0542(12)70161-6

Identifiers

DOI

1 reference

28 August 2017

1 reference